Shengrong Ouyang

Shengrong Ouyang

Auto-generated profile, based on publicly available information

Shengrong Ouyang

Department of Biochemistry and Immunology , Capital Center for Children′s Health , Capital Medical University , Capital Institute of Pediatrics , Beijing , China , shouer.com.cn

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2026 in Journal of Diabetes Research
Verified
Journal Article
Open access
PDF file
HLHuan Liu
Huan Liu
GQGuanming Qi
Guanming Qi
SOShengrong Ouyang
Shengrong Ouyang
FMFeifei Ma
Feifei Ma
Diabetic cardiomyopathy (DCM) is a critical pathological driver of heart failure in diabetic patients, primarily characterized by progressive myocardial fibrosis. Nevertheless, the core molecular network linking upstream metabolic dysregulation to the aberrant activation of downstream cardiac fibroblasts remains largely elusive. In this study, we combined in vivo and in vitro approaches with bioinformatics analysis. A high‐fat diet‐induced mouse model of diabetic myocardial fibrosis was established, and transcriptome sequencing was performed to screen for hub genes, which were subsequently validated in two independent DCM datasets. Single‐cell RNA sequencing revealed that PDK4 and ACOT1 were upregulated in cardiac fibroblasts under pathological conditions. In vitro experiments confirmed that high glucose induced the expression of PDK4, ACOT1, and fibrotic markers in human primary cardiac fibroblasts. Molecular docking predicted a potential interaction between PDK4 and ACOT1. Collectively, our findings identify PDK4 and ACOT1 as evolutionarily conserved metabolic hub genes associated with myocardial fibrosis in DCM, suggesting a putative “metabolism–fibrosis axis” and providing potential therapeutic targets.